CXCL10 and tropical spastic paraparesis: Therefore, it is anticipated that lowering and maintaining low CSF neopterin and CXCL10 levels will lead to improvement and maintenance of the long-term prognosis as demonstrated in corticosteroid-treated patients with HAM/TSP [26–28].